Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$6.05 - $9.74 $5,898 - $9,496
-975 Reduced 0.85%
113,622 $829,000
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $27,300 - $55,098
8,298 Added 7.81%
114,597 $710,000
Q3 2023

Nov 13, 2023

BUY
$3.3 - $4.83 $12,470 - $18,252
3,779 Added 3.69%
106,299 $433,000
Q2 2023

Aug 04, 2023

BUY
$3.23 - $4.95 $331,139 - $507,474
102,520 New
102,520 $347,000
Q2 2022

Aug 12, 2022

SELL
$0.51 - $1.17 $24,466 - $56,129
-47,974 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.65 - $1.18 $2,195 - $3,984
-3,377 Reduced 6.58%
47,974 $51,000
Q4 2021

Feb 11, 2022

BUY
$0.86 - $1.7 $2,561 - $5,062
2,978 Added 6.16%
51,351 $56,000
Q3 2021

Nov 12, 2021

BUY
$1.27 - $8.17 $1,229 - $7,908
968 Added 2.04%
48,373 $64,000
Q2 2021

Aug 13, 2021

BUY
$6.55 - $8.98 $27,889 - $38,236
4,258 Added 9.87%
47,405 $359,000
Q1 2021

May 07, 2021

BUY
$6.1 - $7.69 $701 - $884
115 Added 0.27%
43,147 $286,000
Q4 2020

Feb 12, 2021

SELL
$5.05 - $7.1 $3,282 - $4,615
-650 Reduced 1.49%
43,032 $278,000
Q3 2020

Nov 04, 2020

SELL
$5.25 - $7.08 $5,218 - $7,037
-994 Reduced 2.22%
43,682 $229,000
Q2 2020

Aug 12, 2020

BUY
$5.37 - $8.11 $41,408 - $62,536
7,711 Added 20.86%
44,676 $309,000
Q1 2020

May 04, 2020

BUY
$4.35 - $8.79 $32,329 - $65,327
7,432 Added 25.17%
36,965 $210,000
Q4 2019

Feb 05, 2020

SELL
$4.23 - $8.29 $1,049 - $2,055
-248 Reduced 0.83%
29,533 $222,000
Q3 2019

Nov 08, 2019

SELL
$2.15 - $6.28 $445 - $1,299
-207 Reduced 0.69%
29,781 $140,000
Q2 2019

Aug 13, 2019

BUY
$2.49 - $3.73 $5,258 - $7,877
2,112 Added 7.58%
29,988 $81,000
Q1 2019

May 06, 2019

SELL
$1.88 - $3.35 $1,699 - $3,028
-904 Reduced 3.14%
27,876 $78,000
Q4 2018

Feb 13, 2019

SELL
$1.66 - $4.16 $365 - $915
-220 Reduced 0.76%
28,780 $52,000
Q3 2018

Nov 09, 2018

BUY
$3.75 - $4.65 $26,823 - $33,261
7,153 Added 32.74%
29,000 $126,000
Q2 2018

Aug 08, 2018

BUY
$3.7 - $5.8 $1,838 - $2,882
497 Added 2.33%
21,847 $81,000
Q1 2018

May 07, 2018

SELL
$5.05 - $7.9 $5,797 - $9,069
-1,148 Reduced 5.1%
21,350 $108,000
Q4 2017

Feb 09, 2018

BUY
$4.85 - $7.8 $518 - $834
107 Added 0.48%
22,498 $148,000
Q3 2017

Nov 09, 2017

BUY
$4.35 - $5.7 $97,400 - $127,628
22,391
22,391 $125,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.